Skip to main content

Clinical Trials Using Balstilimab

Review the clinical trials studying balstilimab on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-13 of 13

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
Status: Active
Location: 7 locations
Botensilimab and Balstilimab before Standard Chemotherapy for the Treatment of Mismatch Repair Proficient Rectal Cancer
Status: Active
Location: 7 locations
A Vaccine (Rhsc-Dipgvax) in Combination with Immunotherapy (Balstilimab and Zalifrelimab) for Treatment of Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma in Pediatric Patients
Status: Active
Location: 3 locations
Balstilimab for the Treatment of HPV in Patients with Stage I-III Oropharyngeal Cancer with Persistent HPV Detection
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Radiation Therapy with Dual Immune Checkpoint Inhibitor Therapy (Botensilimab and Balstilimab) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma, Miami EMPIRE Trial
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Botensilimab and Balstilimab with Combination Chemotherapy for the Treatment of Patients with Metastatic Microsatellite Stable Colorectal Cancer
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Microsatellite Stable Localized Rectal Cancer before Surgery
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Botensilimab, Balstilimab, and Liposomal Doxorubicin in Combination with Ultrasound-Mediated Blood Brain Barrier Opening for the Treatment of Patients with Newly Diagnosed Glioblastoma
Status: Active
Location: Northwestern University, Chicago, Illinois
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
AGEN2373 in Combination with GVAX or mKRASvax for the Treatment of Patients with Stage I or II Resectable Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Pooled Mutant KRAS-Targeted Long Peptide Vaccine with Balstilimab and Botensilimab for the Treatment of Patients with Stage IV Non-MSI-H/dMMR Colorectal Cancer and Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for the Treatment of Patients with KRAS-Mutant Metastatic Colorectal Cancer
Status: Active
Location: USC / Norris Comprehensive Cancer Center, Los Angeles, California